Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ishares Genomics Immunology and Healthcare ETF (IDNA)

Ishares Genomics Immunology and Healthcare ETF (IDNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 23,472,000
  • Market Capitalization, $K 23,472
  • Shares Outstanding, K 900
  • 60-Month Beta 2.15
  • Price/Earnings ttm 19.58
  • Annual Dividend & Yield 0.24 (0.92%)
  • Most Recent Dividend 0.240 on 12/16/19
  • Management Fee 0.47%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.32 +22.99%
on 03/16/20
29.10 -5.67%
on 03/09/20
-3.15 (-10.29%)
since 03/06/20
3-Month
22.32 +22.99%
on 03/16/20
31.10 -11.74%
on 03/05/20
-2.06 (-6.97%)
since 01/06/20

Most Recent Stories

More News
Coronavirus Scare Supports These Biotech ETFs & Stocks

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

IBB : 111.71 (+5.14%)
CNCR : 20.23 (+4.11%)
BBH : 133.55 (+4.08%)
ARKG : 31.79 (+6.71%)
AYTU : 1.5700 (-3.09%)
FTSV : 95.51 (+0.05%)
VIR : 36.70 (+26.55%)
IDNA : 27.45 (+4.73%)
CODX : 10.31 (+25.73%)
CNTG : 19.74 (+11.84%)
11-Year Bull Market Nears an End? ETFs That Should Survive

An oil collapse sent Wall Street into a tailspin on Mar 9, indicating that the 11-year-long bull market might soon end. These ETFs may, however, survive the crash.

PSK : 38.38 (+2.90%)
CLIX : 56.91 (+3.65%)
IDNA : 27.45 (+4.73%)
Wall Street in Correction: 4 Sector ETFs Unscathed in February

These sector ETFs gained or lost the least in the coronavirus-induced rout in February.

TSLA : 516.24 (+7.55%)
GLD : 156.88 (+2.77%)
ENPH : 34.05 (+18.68%)
SEDG : 85.15 (+14.33%)
TAN : 25.72 (+7.98%)
SGDM : 22.60 (+5.17%)
CLIX : 56.91 (+3.65%)
KURE : 24.96 (+3.14%)
CNRG : 37.01 (+8.31%)
IDNA : 27.45 (+4.73%)
Will Biotech ETFs Excel in Election Year Post a Surge in 2019?

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

CNCR : 20.23 (+4.11%)
BBC : 29.74 (+7.52%)
PBE : 47.87 (+5.97%)
IBB : 111.71 (+5.14%)
XBI : 80.40 (+7.40%)
SBIO : 32.61 (+9.76%)
IDNA : 27.45 (+4.73%)
HTEC : 23.90 (+6.16%)
Genomics ETFs Surge on CRISPR's Gene Editing Progress

The release of encouraging data on the CRISPR/Cas9 gene-editing therapy CTX001 for two severe blood disorders puts emphasis on some genomic ETFs.

PBE : 47.87 (+5.97%)
VRTX : 255.30 (+7.13%)
CRSP : 42.17 (+7.08%)
ARKG : 31.79 (+6.71%)
IDNA : 27.45 (+4.73%)
GNOM : 12.94 (+5.81%)
Value Biotech ETFs & Stocks to Buy Now

Biotech valuation looks attractive amid a volley of good news. Investors can tap these stocks and ETFs.

ABBV : 75.73 (+3.22%)
BMY : 57.87 (+4.21%)
MRK : 80.31 (+5.32%)
RHHBY : 41.6500 (+1.29%)
LLY : 141.61 (+1.40%)
GSK : 37.91 (+2.07%)
XBI : 80.40 (+7.40%)
BBH : 133.55 (+4.08%)
AMGN : 211.58 (+3.00%)
BIIB : 311.39 (+3.62%)
CELG : 108.24 (+0.10%)
IDNA : 27.45 (+4.73%)
ETFs Poised to Benefit from Gene Editing Revolution

Rising investments and growing technological advancement are favoring the genomic editing space. We take a look at a few ETFs that can cash in on this trend.

AGN : 178.15 (+1.39%)
PBE : 47.87 (+5.97%)
ONCE : 110.05 (-3.10%)
EDIT : 21.35 (+9.15%)
ARKG : 31.79 (+6.71%)
GNOM : 12.94 (+5.81%)
IDNA : 27.45 (+4.73%)
ETFs to Gain From the Booming Genomics Market

Rising investments, surging demand for personalized medicines and shrinking sequencing costs are a slew of factors favouring the genomics space. We look at a few ETFs that can cash in on this trend.

PBE : 47.87 (+5.97%)
ILMN : 278.01 (+5.51%)
IDNA : 27.45 (+4.73%)
GNOM : 12.94 (+5.81%)
ARKG : 31.79 (+6.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade IDNA with:

Fund Summary

The iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of an index composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology, and bioengineering.

See More

Top 10 Holdings

Key Turning Points

2nd Resistance Point 27.80
1st Resistance Point 27.63
Last Price 27.45
1st Support Level 27.10
2nd Support Level 26.74

See More

52-Week High 31.10
Fibonacci 61.8% 27.75
Last Price 27.45
Fibonacci 50% 26.71
Fibonacci 38.2% 25.67
52-Week Low 22.32

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar